Purpose of Review
Despite the recent advancements in diagnostic modalities and therapeutic options available, the pathophysiology of pericardial syndromes remains poorly understood. In this review article, we explore the possible links between cardiac adiposity and pericardial syndromes.
Over the last years, the notion of cardiac adipose tissue has radically changed, and its pivotal role in myocardial diseases has been acknowledged. Recent evidence suggests a cross-talk between epicardial fat and the heart. Imaging of epicardial and pericardial adipose tissue has an independent predictive/prognostic value in cardiovascular disease. Recent data suggests that imaging of epicardial adipose tissue may also provide prognostic information on the clinical course of patients with acute pericarditis.
Evidence from clinical and translational studies suggests possible links between epicardial fat and pericardial diseases, which need to be further explored. Epicardial adipose tissue could have a role both as a prognostic biomarker in pericardial syndromes and as potential therapeutic target for pericardial diseases. The findings of future research in the field are eagerly anticipated.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
- EAT :
Epicardial adipose tissue
- PAT :
Pericardial adipose tissue
Cardiac magnetic resonance
Non-steroidal anti-inflammatory drugs
Positron emission tomography
Acute myocardial infarction
Coronary artery disease
Major adverse coronary events
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Adler Y, Charron P, Imazio M, et al. ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J. 2015;36:2921–64. This is the full text of the most recent guidelines for the diagnosis and management of pericardial diseases.
•• Antonopoulos AS, Sanna F, Sabharwal N, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9:398. Τhe paracrine effects that human vessels exert on the nearby perivascular adipose tissue and the phenotyping of human fat by computed tomography imaging have been shown in this work.
Antonopoulos AS, Margaritis M, Coutinho P, Shirodaria C, Psarros C, Herdman L, et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes. 2015;64:2207–19.
Antonopoulos AS, Margaritis M, Verheule S, Recalde A, Sanna F, Herdman L, et al. Mutual regulation of Epicardial adipose tissue and myocardial redox state by PPAR-gamma/adiponectin signalling. Circ Res. 2016;118:842–55.
Antonopoulos AS, Oikonomou EK, Antoniades C, Tousoulis D. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease. Obes Rev. 2016;17:989–1000.
Antonopoulos AS, Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovasc Res. 2017;113:1074–86.
• Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017;595:3907–17. A comprehensive review on the role of epicardial fat in cardiovascular disease.
• Lazaros G, Antonopoulos AS, Oikonomou EK, et al. Prognostic implications of epicardial fat volume quantification in acute pericarditis. Eur J Clin Invest. 2017;47:129–36. This investigation depicted for the first time an association of epicardial fat volume with the clinical features and outcome of patients with acute pericarditis.
• Vogiatzidis K, Zarogiannis SG, Aidonidis I, et al. Physiology of pericardial fluid production and drainage. Front Physiol. 2015;6:62. Comprehensive review concerning pericardial anatomy and function as well as pericardial space physiology and pericardial fluid turnover regulation.
Rodriguez ER, Tan CD. Structure and anatomy of the human pericardium. Prog Cardiovasc Dis. 2017;59:327–40.
Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85:572–93.
Parmar YJ, Shah AB, Poon M, Kronzon I. Congenital abnormalities of the pericardium. Cardiol Clin. 2017;35:601–64.
Lazaros G, Vlachopoulos C, Stefanadis C. Idiopathic recurrent pericarditis: searching for Ariadne’s thread. Hell J Cardiol. 2009;50:345–51.
•• Imazio M, Lazaros G, Brucato A, Gaita F. Recurrent pericarditis: new and emerging therapeutic options. Nat Rev Cardiol. 2016;13:99–105. Practical guide on the currently available treatment options in difficult to treat patients with recurrent pericarditis.
Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.
• Cremer PC, Kumar A, Kontzias A, et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol. 2016;68:2311–28. Important study which deals with the troublesome subset of patients with complicated pericarditis with respect to their diagnostic approach and treatment.
Lazaros G, Antonatou K, Vassilopoulos D. The therapeutic role of interleukin-1 inhibition in idiopathic recurrent pericarditis: current evidence and future challenges. Front Med (Lausanne). 2017;4:78.
Lazaros G, Imazio M, Brucato A, Tousoulis D. Untying the Gordian knot of pericardial diseases: a pragmatic approach. Hell J Cardiol. 2016;57:315–22.
Imazio M, Brucato A, Maestroni S, Cumetti D, Dominelli A, Natale G, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123:1092–7.
Lazaros G, Karavidas A, Spyropoulou M, Tsiachris D, Halapas A, Zacharoulis A, et al. The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Cardiology. 2011;118:55–62.
Vasileiou P, Tsioufis C, Lazaros G, Hadziyannis E, Kasiakogias A, Stefanadis C, et al. Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Cardiol. 2014;172:e463–4.
Davidovich D, Gastaldelli A, Sicari R. Imaging cardiac fat. Eur Heart J Cardiovasc Imaging. 2013;14:625–30.
Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Cardiol. 2009;22:1311–9.
Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring). 2009;17:625. author reply 627
Mahabadi AA, Berg MH, Lehmann N, Kälsch H, Bauer M, Kara K, et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2013;61:1388–95.
Kunita E, Yamamoto H, Kitagawa T, Ohashi N, Oka T, Utsunomiya H, et al. Prognostic value of coronary artery calcium and epicardial adipose tissue assessed by non-contrast cardiac computed tomography. Atherosclerosis. 2014;233:447–53.
Nakanishi K, Fukuda S, Tanaka A, Otsuka K, Jissho S, Taguchi H, et al. Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease. Atherosclerosis. 2014;237:353–60.
Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham heart study. Eur Heart J. 2009;30:850–6.
Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, et al. The association of pericardial fat with incident coronary heart disease: the multi-ethnic study of atherosclerosis (MESA). Am J Clin Nutr. 2009;90:499–504.
Shah RV, Anderson A, Ding J, Budoff M, Rider O, Petersen SE, et al. Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2017;10:1016–27.
Wang T, Liu Q, Liu C, Sun L, Li D, Liu A, et al. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease in patients with acute myocardial infarction. Echocardiography. 2014;31:1177–81.
Forouzandeh F, Chang SM, Muhyieddeen K, Zaid RR, Trevino AR, Xu J, et al. Does quantifying epicardial and intrathoracic fat with non-contrast computed tomography improve risk stratification beyond calcium scoring alone? Circ Cardiovasc Imaging. 2013;6:58–66.
Mancio J, Azevedo D, Saraiva F, Azevedo AI, Pires-Morais G, Leite-Moreira A, et al. Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2017; https://doi.org/10.1093/ehjci/jex314.
Wu CK, Tsai HY, Su MY, et al. Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure. Atherosclerosis. 2015;241:607–14.
Thanassoulis G, Massaro JM, O'Donnell CJ, Hoffmann U, Levy D, Ellinor PT, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham heart study. Circ Arrhythm Electrophysiol. 2010;3:345–50.
Mahabadi AA, Lehmann N, Kalsch H, Bauer M, Dykun I, Kara K, et al. Association of epicardial adipose tissue and left atrial size on non-contrast CT with atrial fibrillation: the Heinz Nixdorf recall study. Eur Heart J Cardiovasc Imaging. 2014;15:863–9.
Zhu W, Zhang H, Guo L, Hong K. Relationship between epicardial adipose tissue volume and atrial fibrillation: a systematic review and meta-analysis. Herz. 2015;41:421–7.
Antonopoulos AS, Margaritis M, Coutinho P, Digby J, Patel R, Psarros C, et al. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 2014;34(9):2151–9.
Kumar A, Sato K, Yzeiraj E, Betancor J, Lin L, Tamarappoo BK, et al. Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis. JACC Cardiovasc Imaging. 2017;10:1337–46.
Cremer PC, Tariq MU, Karwa A, Alraies MC, Benatti R, Schuster A, et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging. 2015;8(5):e003125. https://doi.org/10.1161/CIRCIMAGING.114.003125.
Horckmans M, Bianchini M, Santovito D, Megens RTA, Springael JY, Negri I, et al. Pericardial adipose tissue regulates Granulopoiesis, fibrosis and cardiac function after myocardial infarction. Circulation. 2017;137:948–60. https://doi.org/10.1161/CIRCULATIONAHA.117.028833.
Conflict of Interest
George Lazaros, Alexios Antonopoulos, Charalambos Antoniades, and Dimitris Tousoulis declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Pericardial Disease
About this article
Cite this article
Lazaros, G., Antonopoulos, A., Antoniades, C. et al. The Role of Epicardial Fat in Pericardial Diseases. Curr Cardiol Rep 20, 40 (2018). https://doi.org/10.1007/s11886-018-0986-7